Microvessels invasion in resected N0 locally advanced NSCLC

A. Akopov, I. V. Dvorakovskaya, V. Egorov (St Petersburg, Russia)

Source: Annual Congress 2003 - Lung cancer management and prognosis
Session: Lung cancer management and prognosis
Session type: Oral Presentation
Number: 2548
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Akopov, I. V. Dvorakovskaya, V. Egorov (St Petersburg, Russia). Microvessels invasion in resected N0 locally advanced NSCLC. Eur Respir J 2003; 22: Suppl. 45, 2548

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Intratumoral microvessels, pTNM stage and survival in resected NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 325s
Year: 2005

Analysis of risk factors for brain metastasis in locally advanced stage non-small cell carcinoma
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010

Radical radiotherapy in medically inoperable early stage non-small cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 318s
Year: 2001

Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment
Source: Eur Respir J 2009; 33: 1383-1388
Year: 2009



Impact of neoadjuvant therapy on tumor resectability and survival of patients with locally advanced non-small cell lung cancer
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011


How to treat a T1-T3N0 non-small cell lung cancer (NSCLC) with isolated brain metastasis
Source: International Congress 2015 – How to treat brain metastases
Year: 2015



Independent prognostic und predictive value of blood vessel invasion (BVI) in curatively (R0) resected stage II and IIIA non-small cell lung (NSCLC) cancer patients
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Management of locally advanced nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 260–270
Year: 2009

Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer
Source: Eur Respir J 2013; 41: 649-655
Year: 2013



Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
Source: Eur Respir Rev 2015; 25: 65-70
Year: 2016



Pulmonary re-biopsy in non–small-cell lung cancer (NSCLC) locally advanced or metastatic  with EGFR-T790M resistance.
Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound
Year: 2018

Lymph nodes frozen section in staging of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 534s
Year: 2005

The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Disease relapse in surgically and conservatively treated patients with stage I-II of non-small cell lung cancer
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010

Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018
Year: 2019



Prognostic factors in patients with resected pathologic stage I and II nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002

TTF-1 for prediction of response to chemotherapy in patients with locally advanced or metastatic small cell lung cancer (SCLC)
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012

Surgically resected bronchioloalveolar carcinoma – T-status, N-status, pTNM stage and survival
Source: Eur Respir J 2006; 28: Suppl. 50, 750s
Year: 2006